Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2024	Mar. 31, 2024
ASSETS
Cash and cash equivalents	$ 10,209	$ 8,570
Restricted cash and cash equivalents	2,183	2,251
Investments in marketable securities	4,781	4,505
Finance receivables, net of allowance for credit losses of $1,656 and $1,637, respectively	103,237	101,669
Investments in operating leases, net	28,710	28,013
Other assets	4,431	4,373
Total assets	153,551	149,381
LIABILITIES AND SHAREHOLDER'S EQUITY
Debt	125,956	122,420
Deferred income taxes	2,670	3,272
Other liabilities	7,138	6,707
Total liabilities	135,764	132,399
Commitments and contingencies (Refer to Note 9)
Shareholder's equity:
Capital stock, no par value (100,000 shares authorized; 91,500 issued and outstanding) at September 30, 2024 and March 31, 2024	915	915
Additional paid-in capital	2	2
Accumulated other comprehensive loss	(46)	(65)
Retained earnings	16,916	16,130
Total shareholder's equity	17,787	16,982
Total liabilities and shareholder's equity	$ 153,551	$ 149,381